Publication: 849

Publication: 849

PAM50 gene signature is prognostic for breast cancer patients treated with adjuvant anthracycline and taxane based chemotherapy

URL

Google Scholar

Citation:: Cancer Res vol 72 (24 supplement) abstract P2-10-01

Meeting Instance:: AACR 2012
Year:: 2012
Type:: Abstract
Sub type:: Poster General
Funding:: NCTN
Endpoint:: Secondary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pub

Note:

Methodological:: No
Biospecimen:: Yes
SDC:: Yes

Parents:: None
Children:: 2088

Program:: TRP
Primary Committee:: Correl Sci NOS
Sec. Committees:

Pharmas:
Grants:

Corr. Author:
Authors:: M. Liu B. Pitcher E. Mardis S. Davies J. Snider T. Vickery J. Reed K. Deschryver B. Singh P. Friedman W. Gradishar E. Perez S. Martino M. Citron L. Norton E. Winer C. Hudis C. Perou M. Ellis W. Barry

Networks:

Study: CALGB-9741
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords: